Bio:

Dr. Konopka is a clinical neuroscientist and psychologist with expertise in human psychophysiology/pharmacology and utilization of his Brain to Behavior Approach to diagnosis and treatment.

He interprets each patient’s brain functionality by considering their genetic vulnerabilities, developmental milestones, sensory processing, and neurobehavioral presentation as substrates for developing personalized treatment approaches. Diagnostically, in addition to the standard clinical evaluation, Dr.Konopka relies on qEEG, physiological data from evoked potentials, emotional activation studies, and emotional and cognitive neurobehavioral testing.  Therapeutically, Dr. Konopka uses a behavioral and physiological approach that incorporates traditional individual and family therapy.

“I am passionate about helping each patient optimize their unique potential. My goal is to partner with individuals to face life’s challenges and achieve the physiological, cognitive, and emotional flexibility that allows for symptom management through my Brain to Behavior Approach.”

Dr. Konopka’s background allows him to effectively use biofeedback, neurofeedback, and other neuro-modulating tools such as transcranial stimulation. In addition, he also employs therapeutics based on cognitive behavioral methods, family systems, psychodynamic theories, art, music, creative writing, and other expressive modalities. Dr. Konopka strives to help each patient achieve the physiological, cognitive, and emotional flexibility that allows for symptom management and, ultimately, brain remodeling so that the patient can face life’s challenges and optimize their unique potential.

Videos:

Treats most conditions, specializes in:

  • Attention Deficit Disorder
  • ADHD
  • Anxiety
  • Brain Injury
  • Complex Presentations
  • Depression
  • Dementia
  • Treatment Resistance

Insurance

Accepts Most Insurance

Ages Seen

Therapy 16-65

qEEG 5 and up

Locations

  • Morris
  • Romeoville

Dr. Konopka's Publications

    • Exercise vs competitive athletics in youth: a neuroscience perspective. 
      Konopka, L. M.
      Croatian Medical Journal. 2015. 56(6), 581–582.
    • The “Brain to Behavior Approach” to diagnosis and treatment. 
      Konopka, L. M.
      Croatian Medical Journal. 2015. 56(5), 500–502.
    • Near death experience: neuroscience perspective. 
      Konopka, L. M.
      Croatian Medical Journal. 2015. 56(4), 392–393.
    • The impact of child abuse: neuroscience perspective. 
      Konopka, L. M.
      Croatian Medical Journal. 2015. 56(3), 315–316.
    • How exercise influences the brain: a neuroscience perspective. 
      Konopka, L. M.
      Croatian Medical Journal. 2015. 56(2), 169–171.
    • A neuroscience perspective on incidental imaging findings and diagnostic and therapeutic silos. 
      Konopka, L. M.
      Croatian Medical Journal. 2015. 56(1), 68–69.
    • Genetic vulnerability in patients with psychiatric presentations: a neuroscience perspective.
      Konopka, L. M.
      Croatian Medical Journal. 2014. 55(5), 545–546.
    • Neuroscience prospective on education. 
      Konopka, L. M.
      Croatian Medical Journal. 2014. 55(4), 428–430.
    • Marijuana use: neuroscience perspective. 
      Konopka, L. M.
      Croatian Medical Journal. 2014. 55(3), 281–283.
    • Effects of Drawing on Alpha Activity: A Quantitative EEG Study with Implications for Art Therapy.
      Belkofer, C. M., Van Hecke, A. V., & Konopka, L. M.
      Art Therapy. 2014. 31(2), 61–68.
    • Understanding attention deficit disorder: a neuroscience prospective.
      Konopka, L. M.
      Croatian Medical Journal. 2014. 55(2), 174–176.
    • Preliminary Findings of Single- and Multifocused Epileptiform Discharges in Nonepileptic Psychiatric Patients.
      Zimmerman, E. M., & Konopka, L. M.
      Clinical EEG and Neuroscience. 2014. 45(4), 285–292.
    • Where art meets neuroscience: a new horizon of art therapy.
      Konopka, L. M.
      Croatian Medical Journal. 2014. 55(1), 73–74.
    • Neuroscience and psychiatric patients: does the brain matter? Konopka, L. M.
      Croatian Medical Journal. 2013. 54(6), 598–599.
    • Conscious Attention, Meditation, and Bilateral Information Transfer.
      Bob, P., Zimmerman, E. M., Hamilton, E. A., Sheftel, J. G., Bajo, S. D., Raboch, J., … Konopka, L. M.
      Clinical EEG and Neuroscience. 2012. 44(1), 39–43.
    • Multimodality-Driven Diagnostic Interventions: Complex Mild Traumatic Brain Injury.
      Epstein, P., Z. Zimmerman, E., M. Jensen, K., & Konopka, L.
      Journal of Neuropsychiatry. 2012. 24(2):22-22.
    • Use of Multimodality Imaging and Neuropsychological Measures for the Assessment and Treatment of Auditory Verbal Hallucinations: A Brain to Behavior Approach.
      Zimmerman, E. M., Golla, M. A., Paciora, R. A., Epstein, P. S., & Konopka, L. M.
      Activitas Nervosa Superior. 2011. 53(3), 150–158.
    • Person-centered medicine versus personalized medicine: Is it just a sophism? A view from chronic pain management.
      Braš, M., Dorđević, V., Milunović, V., Brajkovic, L., Milicic, D., & Konopka, L.
      Psychiatria Danubina. 2011. 23(3), 245–399.
    • Community-Based Electrophysiological Abnormalities in Children With ADHD: Translating Research Findings into a Clinical Setting.
      Martin, C. N., & Konopka, L. M.
      Activitas Nervosa Superior. 2011. 53(3), 129–140.
    • EEG Complexity and Attentional Processes Related to Dissociative States.
      Bob, P., Golla, M., Epstein, P., & Konopka, L.
      Clinical EEG and Neuroscience. 2011. 42(3), 175–179.
    • Intensity-Dependent Auditory Evoked Potential Defines Subgroups of Patients with PTSD: A Multimodality Imaging Study.
      Poprawski, T. J., Lonser, K. A., Korpics, J., Zadecki, J., Crayton, J. W., Halaris, A., & Konopka, L. M.
      Activitas Nervosa Superior. 2009. 51(3), 109–119.
    • Compulsive Hoarding in an Older Adult with Aggression, Delusions and Memory Loss: A Multimodality Neuroimaging Study.
      Chennamchetty, V. N., Poprawski, T. J., Crayton, J. W., Hamilton, E. A., & Konopka, L. M.
      Activitas Nervosa Superior. 2009. 51(1), 6–11.
    • Conducting Art Therapy Research Using Quantitative EEG Measures.
      Belkofer, C. & Konopka, L. M.
      Art Therapy. 2008. 25(2), 56–63.
    • Multimodality Imaging in a Depressed Patient with Violent Behavior and Temporal Lobe Seizures.
      Poprawski, T. J., Pluzyczka, A. N., Park, Y., Chennamchetty, V. N., Halaris, A., Crayton, J. W., & Konopka, L. M.Clinical EEG and Neuroscience. 2007. 38(3), 175–179.
    • Similar or Disparate Brain Patterns? The Intra-Personal EEG Variability of Three Women with Multiple Personality Disorder.
      Lapointe, A. R., Crayton, J. W., DeVito, R., Fichtner, C. G., & Konopka, L. M.
      Clinical EEG and Neuroscience. 2006. 37(3), 235–242.
    • Frontal Alpha Power Asymmetry in Aggressive Children and Adolescents with Mood and Disruptive Behavior Disorders.
      Rybak, M., Crayton, J. W., Young, I. J., Herba, E., & Konopka, L. M.
      Clinical EEG and Neuroscience. 2006. 37(1), 16–24.
    • EEG Databases in Research and Clinical Practice: Current Status and Future Directions.
      Gordon, A., Konopka, L.M.
      Clinical EEG and Neuroscience. 2005. 36(2), 53–54.
    • Double-blind trial of the effects of tryptophan depletion on depression and cerebral blood flow in smokers.
      Pergadia, M., Spring, B., Konopka, L. M., Twardowska, B., Shirazi, P., & Crayton, J. W.
      Addictive Behaviors. 2004. 29(4), 665–671.
    • Quantitative Electroencephalography in Frontotemporal Dementia with Methylphenidate Response: A Case Study.
      Goforth, H. W., Konopka, L., Primeau, M., Ruth, A., O’Donnell, K., Patel, R., … Rao, M.
      Clinical EEG and Neuroscience. 2004. 35(2), 108–111.
    • Changes in Regional Cerebral Blood Flow After Electroconvulsive Therapy for Depression.
      Milo, T., Kaufman, G., Barnes, E., Konopka, L., Crayton, J., Ringelstein, J., & Shirazi, P.
      The Journal of ECT. 2001. 17(1), 15–21.
    • Individual differences among cocaine users.
      Gunnarsdóttir, E. D., Pingitore, R. A., Spring, B. J., Konopka, L. M., Crayton, J. W., Milo, T., & Shirazi, P.
      Addictive Behaviors. 2000. 25(5), 641–652.
    • Platelet cytosolic calcium hyperresponsivity to serotonin in patients with hypertension and depressive symptoms.
      Delisi, J. S. M., Konopka, L. M., Russell, K., O’Connor, F. L., Cooper, R., & Crayton, J.
      Biological Psychiatry. 1999. 45(8), 1035–1041.
    • Platelet Cytosolic Calcium Responses to Serotonin in Depressed Patients and Controls: Relationship to Symptomatology and Medication.
      Delisi, S. M., Konopka, L. M., O’Connor, F. L., & Crayton, J. W.
      Biological Psychiatry. 1998. 43(5), 327–334.
    • Serotonin-induced increases in platelet cytosolic calcium concentration in depressed, schizophrenic, and substance abuse patients.
      Konopka, L. M., Cooper, R., & Crayton, J. W.
      Biological Psychiatry. 1996. 39(8), 708–713.
    • Spontaneous transients of [Ca2+]i depend on external calcium and the activation of L-type voltage-gated calcium channels in a clonal pituitary cell line (AtT-20) of cultured mouse corticotropes.
      Fiekers, J. F., & Konopka, L. M.
      Cell Calcium. 1996. 19(4), 327–336.
    • “Unusual Tc-99 HMPAO brainpatterns in neurological and neuropsychiatric disorders”.
      Papatheofanis F.J., Shirazi P.H., Konopka L.M., Crayton J.W.
      Radiographic 15:1270, Selected Scientific Exhibits in Neuro-Radiology, Supplement 2, 1995.
    • Serotonin-induced changes in membrane potential and cytosolic free calcium in a clonal pituitary cell line (AtT-20) of cultured mouse corticotropes.
      Fiekers, J. F., & Konopka, L. M.
      Life Sciences. 1994. 55(1), 15–26.
    • Bethanechol-induced responses in mudpuppy parasympathetic neurons.
      Konopka, L. M., & Parsons, R. L.
      Neuropharmacology. 1992. 31(12), 1311–1321.
    • Aminergic and peptidergic elements and actions in a cardiac parasympathetic ganglion.
      Konopka, L. M., Merriam, L., Hardwick, J., & L. Parsons, R.
      Canadian Journal of Physiology and Pharmacology. 1992. 70:s32-s43.
    • Galanin-like innervation of rat submandibular and sublingual salivary glands: Origin and effect on acinar cell membranes.
      Konopka, L. M., May, V., & Forehand, C. J.
      Journal of Comparative Neurology. 1992. 317(3), 271–282.
    • Analysis of the galanin-induced decrease in membrane excitability in mudpuppy parasympathetic neurons. 
      Parsons, R. L., & Konopka, L. M.
      Neuroscience. 1991. 43(2), 647–660.
    • Galanin as an inhibitory transmitter in the mudpuppy cardiac ganglion. 
      McKeon, T. W., Konopka, L. M., & Parsons, R. L.
      Journal of the Autonomic Nervous System. 1991. 33(2), 119–120.
    • Galanin in a parasympathetic ganglion. 
      Konopka, L.M., McKeon, T.W., Merriam, L.A., Hardwick, J.C., Parsons, R.L.
      In: Hokfelt T, Bartfai T., eds. Galanin: A new multifunctional peptide in the neuroendocrine system.
      New York: MacMillan Press. 1991.
    • Galanin-induced hyperpolarization of mudpuppy neurons is calcium dependent.
      Parsons, R. L., & Konopka, L. M.
      Neuroscience Letters. 1990. 115(2), 207–212.
    • Distribution of galanin-like peptide in various tissues of Necturus
      McKeon, T. W., Carraway, R. E., Konopka, L. M., & Parsons, R. L.
      Cell and Tissue Research. 1990. 262(3), 461–466.
    • Frog sympathetic ganglion cells have local axon collaterals. 
      Forehand, C. J., & Konopka, L. M.
      Journal of Comparative Neurology. 1989. 289(2), 294–303.
    • Characteristics of the galanin-induced depolarization of mudpuppy parasympathetic postganglionic neurons. 
      Konopka, L. M., & Parsons, R. L.
      Neuroscience Letters. 1989. 99(1), 142–146.
    • Galanin-induced hyperpolarization and decreased membrane excitability of neurones in mudpuppy cardiac ganglia. 
      Konopka, L. M., McKeon, T. W., & Parsons, R. L.
      The Journal of Physiology. 1989. 410, 107–122.
    • The presence and possible role of a galanin-like peptide in the mudpuppy heart. 
      Parsons, R.L., Neel, D.S., Konopka, L.M., McKeon, T.W.
      Neuroscience. 1989. 29, 749-759.
    • Clindamycin-induced alteration of ganglionic function. II. Effect of nicotinic receptor-channel function. 
      Konopka, L. M., Neel, D. S., & Parsons, R. L.
      Brain Research. 1988. 458(2), 278–284.
    • Clindamycin-induced alteration of ganglionic function. I. Direct effects on ganglion cell properties. 
      Konopka, L. M., & Parsons, R. L.
      Brain Research. 1988. 458(2), 269–277.
    • Localization of Postganglionic Neurons to the Male Genital Organ in the Major Pelvic Ganglion of the Rat. 
      Shimzu, T., Egan-Konopka, L. M., Ohta, Y., & Dun, N. J.
      The Tohoku Journal of Experimental Medicine. 1982. 136(3), 351–352.